Literature DB >> 1747146

Induction of arthritis in rats by soluble peptidoglycan-polysaccharide complexes produced by human intestinal flora.

J Kool1, J G Ruseler-van Embden, L M van Lieshout, H de Visser, M Y Gerrits-Boeye, W B van den Berg, M P Hazenberg.   

Abstract

Peptidoglycan-polysaccharide complexes were isolated from feces of a healthy subject and from ileostomy fluid from 5 patients. Peptidoglycan-polysaccharide complexes were tested for arthritogenicity in a rat model, by subcutaneous injection in Freund's incomplete adjuvant. Complexes from the healthy subject did not induce arthritis, but those from ileostomy fluid of 1 of the patients induced severe, chronic joint inflammation. We concluded that peptidoglycan-polysaccharide complexes from intestinal flora are potentially arthritogenic in rats. This arthritogenicity may be influenced by the content of muramic acid and rhamnose in these complexes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1747146     DOI: 10.1002/art.1780341222

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  4 in total

Review 1.  Normal intestinal microbiota in the aetiopathogenesis of rheumatoid arthritis.

Authors:  P Toivanen
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

Review 2.  Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans.

Authors:  J H Schwab
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

3.  Responses of synovial fluid and peripheral blood mononuclear cells to bacterial antigens and autologous antigen presenting cells.

Authors:  I S Klasen; M J Melief; T J Swaak; A J Severijnen; M P Hazenberg
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

Review 4.  Association Between Gut Microbiota and Osteoarthritis: A Review of Evidence for Potential Mechanisms and Therapeutics.

Authors:  Zhentian Wei; Feng Li; Guofu Pi
Journal:  Front Cell Infect Microbiol       Date:  2022-03-16       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.